XML 30 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Total Stryker shareholders' equity
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non-controlling interest
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest             $ 0.0
Balance at beginning of period at Dec. 31, 2014     $ 38.0 $ 1,252.0 $ 7,559.0 $ (254.0)  
Beginning balance, shares at Dec. 31, 2014 378.6            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under stock option and benefit plans       8.0      
Issuance of common stock under stock option and benefit plans, shares 1.8            
Repurchase of common stock     (1.0) (25.0) (674.0)    
Repurchase of common stock, shares (7.4)            
Share-based compensation       86.0      
Net earnings $ 1,439.0       1,439.0   0.0
Cash dividends declared         (532.0)    
Other comprehensive income (loss) $ (385.0)         (385.0)  
Balance at end of period at Dec. 31, 2015   $ 8,511.0 37.0 1,321.0 7,792.0 (639.0)  
Ending balance, shares at Dec. 31, 2015 373.0            
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 8,511.0           0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Acquisitions             0.0
Interest purchased             0.0
Foreign currency exchange translation adjustment             0.0
Issuance of common stock under stock option and benefit plans       15.0      
Issuance of common stock under stock option and benefit plans, shares 1.7            
Repurchase of common stock       (1.0) (12.0)    
Repurchase of common stock, shares (0.1)            
Share-based compensation       97.0      
Net earnings $ 1,647.0       1,647.0   0.0
Cash dividends declared         (585.0)    
Other comprehensive income (loss) (122.0)         (122.0)  
Balance at end of period at Dec. 31, 2016 $ 9,550.0 9,550.0 37.0 1,432.0 8,842.0 (761.0)  
Ending balance, shares at Dec. 31, 2016 374.6            
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 9,550.0           0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Acquisitions             0.0
Interest purchased             0.0
Foreign currency exchange translation adjustment             0.0
Issuance of common stock under stock option and benefit plans     0.0 (42.0)      
Issuance of common stock under stock option and benefit plans, shares 1.7            
Repurchase of common stock $ (230.0)   0.0 (7.0) (223.0)    
Repurchase of common stock, shares (1.9)            
Share-based compensation       113.0      
Net earnings $ 1,020.0       1,020.0   0.0
Cash dividends declared         (653.0)    
Other comprehensive income (loss) 208.0         208.0  
Balance at end of period at Dec. 31, 2017 $ 9,966.0 $ 9,966.0 $ 37.0 $ 1,496.0 $ 8,986.0 $ (553.0)  
Ending balance, shares at Dec. 31, 2017 374.4            
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 9,980.0           14.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Acquisitions             114.0
Interest purchased             (99.0)
Foreign currency exchange translation adjustment             $ (1.0)